PupillOmetry for Prediction of DelirIUM
PODIUM
Automated Pupillometry and Delirium in Patients on Mechanical Ventilation in Intensive Care-intensive Care
2 other identifiers
observational
213
1 country
1
Brief Summary
Delirium in intensive care unit (ICU) is a serious event. It is associated with short-term complications (agitation, self-extubation, accidental removal of catheters, prolonged length of stay and ventilation), excess mortality, functional and cognitive impairment. It is particularly frequent in patients requiring mechanical ventilation but diagnosis is not easy. There are screening scales, but it is insufficiently used in clinical practice: Confusion Assessment Method for the Intensive Care Unit (CAM-ICU) or Intensive Care Delirium Screening Checklist (ICDSC). These scales are time consuming and require trained personnel. Automated pupillometry (AP) is a new device to objectively, rapidly, and reproducibly identify acute brain dysfunction. Recent data suggest that AP could be used to predict delirium in the ICU. This would need to be validated for routine use in the ICU. Evaluate AP parameters on day 3 of invasive mechanical ventilation as a predictive tool for CAM-ICU diagnosed delirium during the first 14 days of ICU stay. Study design: Prospective, multicenter, non-interventional cohort Measurement of the AP parameters at day 3 after ICU admission and their predictive performance for delirium: pupillary diameter, variation of the pupillary diameter, pupillary constriction speed, pupillary dilatation speed, photomotor reflex latency, NPi and symmetry of pupillary responses.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Apr 2022
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 9, 2021
CompletedFirst Posted
Study publicly available on registry
February 21, 2022
CompletedStudy Start
First participant enrolled
April 15, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 15, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
March 1, 2026
CompletedJanuary 12, 2026
January 1, 2026
2.6 years
December 9, 2021
January 8, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Measurement of the parameters of the automated pupillometry
at day 0
Secondary Outcomes (10)
Measurement of the parameters of the automated pupillometry
until 7 days
Rate of agitated patients (agitation is defined by a Richmond Agitation-Sedation Scale > +1(RASS score: +4; -5 with 0= better outcome) requiring use of neuroleptics or dexmedetomidine)
until day14 of resuscitation or discharge from resuscitation
Self-extubation rate
until day14 or stop invasive ventilation
Accidental catheter ablation rate
up to day14 resuscitation or resuscitation discharge
Number of days of mechanical ventilation
until D14 or stopping invasive ventilation
- +5 more secondary outcomes
Study Arms (1)
Patient
Adult patient hospitalized in ICU for a duration of mechanical ventilation longer than 48 hours
Interventions
acquisition of dynamic parameters in addition to pupillary diameter, such as . pupillary diameter, variation of the pupillary diameter, pupillary constriction speed, pupillary dilatation speed, photomotor reflex latency, NPi and symmetry of pupillary responses after a standardized light stimulus
Eligibility Criteria
Adult patient hospitalized in ICU for a duration of mechanical ventilation longer than 48 hours
You may qualify if:
- Adults ≥ 18 years
- mechanical ventilation since 48h
You may not qualify if:
- Patient diagnosed confused by CAM-ICU on D0
- Ophthalmological pathology modifying the photomotor reflex
- Acute or chronic neurological pathology: Cerebro-injured patients (head trauma, stroke, cardiopulmonary arrest, hypoglycemic coma, meningitis / encephalitis / brain abscess), dementia with MMSE \<24
- Duration of stay in intensive care\> 72h or duration of ventilation\> 72h
- Readmission in intensive care
- Moribund patient
- Patient under guardianship or curatorship
- No affiliation to social security (beneficiary or assignee)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Hôpital Bichat-Claude Bernard
Paris, 75018, France
Related Publications (1)
Jaquet P, Couffignal C, Tardivon C, Godard V, Bellot R, Assouline B, Benghanem S, Da Silva D, Decavele M, Dessajan J, Hermann B, Rambaud T, Voiriot G, Sonneville R; PODIUM Study Group. PupillOmetry for preDIction of DeliriUM in ICU (PODIUM): protocol for a prospective multicentre cohort study. BMJ Open. 2023 Jul 12;13(7):e072095. doi: 10.1136/bmjopen-2023-072095.
PMID: 37438060DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Pierre Jaquet, MD
Assistance Publique Hopitaux de Paris
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
December 9, 2021
First Posted
February 21, 2022
Study Start
April 15, 2022
Primary Completion
November 15, 2024
Study Completion
March 1, 2026
Last Updated
January 12, 2026
Record last verified: 2026-01